Anna Beronius

1.6k total citations
53 papers, 818 citations indexed

About

Anna Beronius is a scholar working on Health, Toxicology and Mutagenesis, Food Science and Small Animals. According to data from OpenAlex, Anna Beronius has authored 53 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Health, Toxicology and Mutagenesis, 14 papers in Food Science and 11 papers in Small Animals. Recurrent topics in Anna Beronius's work include Effects and risks of endocrine disrupting chemicals (38 papers), Agricultural safety and regulations (14 papers) and Animal testing and alternatives (11 papers). Anna Beronius is often cited by papers focused on Effects and risks of endocrine disrupting chemicals (38 papers), Agricultural safety and regulations (14 papers) and Animal testing and alternatives (11 papers). Anna Beronius collaborates with scholars based in Sweden, Netherlands and Italy. Anna Beronius's co-authors include Annika Hanberg, Christina Rudén, Johanna Zilliacus, Marlene Ågerstrand, Helen Håkansson, Hilko van der Voet, Mirjam Luijten, Laura N. Vandenberg, Niklas Johansson and Nicolas Roth and has published in prestigious journals such as SHILAP Revista de lepidopterología, Environment International and Food and Chemical Toxicology.

In The Last Decade

Anna Beronius

50 papers receiving 794 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Beronius Sweden 18 537 148 104 99 93 53 818
Elisabet Berggren Italy 10 318 0.6× 100 0.7× 199 1.9× 80 0.8× 66 0.7× 23 688
Christopher J. Borgert United States 16 509 0.9× 184 1.2× 58 0.6× 120 1.2× 63 0.7× 37 776
Richard C. Hertzberg United States 18 672 1.3× 146 1.0× 47 0.5× 208 2.1× 98 1.1× 37 1.0k
Harrie Buist Netherlands 17 297 0.6× 59 0.4× 136 1.3× 102 1.0× 117 1.3× 31 800
Andrew J. Shapiro United States 11 465 0.9× 120 0.8× 135 1.3× 109 1.1× 33 0.4× 19 773
Elise Grignard Italy 7 441 0.8× 151 1.0× 70 0.7× 70 0.7× 91 1.0× 9 646
Michael Dellarco United States 11 359 0.7× 96 0.6× 47 0.5× 97 1.0× 53 0.6× 27 614
Emiel Rorije Netherlands 22 449 0.8× 204 1.4× 167 1.6× 153 1.5× 109 1.2× 72 1.1k
Alain‐Claude Roudot France 19 457 0.9× 142 1.0× 49 0.5× 75 0.8× 95 1.0× 76 1.0k
Etje Hulzebos Netherlands 15 319 0.6× 145 1.0× 161 1.5× 83 0.8× 79 0.8× 26 774

Countries citing papers authored by Anna Beronius

Since Specialization
Citations

This map shows the geographic impact of Anna Beronius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Beronius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Beronius more than expected).

Fields of papers citing papers by Anna Beronius

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Beronius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Beronius. The network helps show where Anna Beronius may publish in the future.

Co-authorship network of co-authors of Anna Beronius

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Beronius. A scholar is included among the top collaborators of Anna Beronius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Beronius. Anna Beronius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wincent, Emma, et al.. (2025). Using transcriptomics data and Adverse Outcome Pathway networks to explore endocrine disrupting properties of Cadmium and PCB-126. Environment International. 197. 109352–109352. 3 indexed citations
2.
Axelstad, Marta, et al.. (2025). Assessment of endocrine disruptors in the European Union: Current regulatory framework, use of new approach methodologies (NAMs) and recommendations for improvements. Regulatory Toxicology and Pharmacology. 162. 105883–105883. 3 indexed citations
3.
Rosenmai, Anna Kjerstine, Eleftheria Maria Panagiotou, Johanna Zilliacus, et al.. (2025). A pragmatic upstream network for disrupted steroidogenesis through reduced enzyme activity and steroid hormone production for Adverse Outcome Pathway building. Reproductive Toxicology. 139. 109105–109105.
4.
5.
Beronius, Anna, et al.. (2024). Fulfilling the criteria for CLP classification: the implications for substances under the EU chemicals legislation. SHILAP Revista de lepidopterología. 6. 1452065–1452065. 1 indexed citations
6.
Clerbaux, Laure‐Alix, Penny Nymark, Vinita Chauhan, et al.. (2023). Beyond chemicals: Opportunities and challenges of integrating non-chemical stressors in adverse outcome pathways. ALTEX. 41(2). 233–247. 7 indexed citations
7.
Beronius, Anna, et al.. (2023). SciRAPnano: a pragmatic and harmonized approach for quality evaluation of in vitro toxicity data to support risk assessment of nanomaterials. SHILAP Revista de lepidopterología. 5. 1319985–1319985. 4 indexed citations
8.
Beronius, Anna, et al.. (2022). Stricter regulation applies to antimicrobial substances when used as biocides compared to cosmetics under current EU legislation. Emerging contaminants. 8. 229–242. 11 indexed citations
9.
Clerbaux, Laure‐Alix, Maria Cristina Albertini, Núria Amigó, et al.. (2022). Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework. Journal of Clinical Medicine. 11(15). 4464–4464. 20 indexed citations
10.
Beronius, Anna, et al.. (2022). Systematic evaluation of the evidence for identification of endocrine disrupting properties of Bisphenol F. Toxicology. 476. 153255–153255. 9 indexed citations
11.
Menegola, Elena, Francesca Di Renzo, Angelo Moretto, et al.. (2021). An adverse outcome pathway on the disruption of retinoic acid metabolism leading to developmental craniofacial defects. Toxicology. 458. 152843–152843. 18 indexed citations
12.
Escrivá, Laura, et al.. (2020). A validated search filter for the identification of endocrine disruptors based on the ECHA/EFSA guidance recommendations. Environment International. 142. 105828–105828. 3 indexed citations
13.
Beronius, Anna, Johanna Zilliacus, Annika Hanberg, et al.. (2020). Methodology for health risk assessment of combined exposures to multiple chemicals. Food and Chemical Toxicology. 143. 111520–111520. 43 indexed citations
14.
Rotter, Stefanie, Anna Beronius, Alan R. Boobis, et al.. (2018). Overview on legislation and scientific approaches for risk assessment of combined exposure to multiple chemicals: the potential EuroMix contribution. Critical Reviews in Toxicology. 48(9). 796–814. 77 indexed citations
15.
Beronius, Anna, Laurent Bodin, Bas Bokkers, et al.. (2017). Evaluating the evidence for non-monotonic dose-response relationships: A systematic literature review and (re-)analysis of in vivo toxicity data in the area of food safety. Toxicology and Applied Pharmacology. 339. 10–23. 26 indexed citations
16.
Beausoleil, Claire, Anna Beronius, Laurent Bodin, et al.. (2016). Review of non‐monotonic dose‐responses of substances for human risk assessment. EFSA Supporting Publications. 13(5). 32 indexed citations
17.
Beronius, Anna & Laura N. Vandenberg. (2015). Using systematic reviews for hazard and risk assessment of endocrine disrupting chemicals. Reviews in Endocrine and Metabolic Disorders. 16(4). 273–287. 23 indexed citations
18.
Beronius, Anna, Niklas Johansson, Christina Rudén, & Annika Hanberg. (2013). The influence of study design and sex-differences on results from developmental neurotoxicity studies of bisphenol A, implications for toxicity testing. Toxicology. 311(1-2). 13–26. 40 indexed citations
19.
Beronius, Anna, Christina Rudén, Annika Hanberg, & Helen Håkansson. (2009). Health risk assessment procedures for endocrine disrupting compounds within different regulatory frameworks in the European Union. Regulatory Toxicology and Pharmacology. 55(2). 111–122. 18 indexed citations
20.
Beronius, Anna, Christina Rudén, Helen Håkansson, & Annika Hanberg. (2009). Risk to all or none?. Reproductive Toxicology. 29(2). 132–146. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisabet Berggren Breakdown of academic impact, for papers by Christopher J. Borgert Breakdown of academic impact, for papers by Richard C. Hertzberg Breakdown of academic impact, for papers by Harrie Buist Breakdown of academic impact, for papers by Andrew J. Shapiro Breakdown of academic impact, for papers by Elise Grignard Breakdown of academic impact, for papers by Michael Dellarco Breakdown of academic impact, for papers by Emiel Rorije Breakdown of academic impact, for papers by Alain‐Claude Roudot Breakdown of academic impact, for papers by Etje Hulzebos
Rankless by CCL
2026